Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
Paul Emery, MA, MD, FRCP

Professor of Rheumatology
Academic Unit of Musculoskeletal Disease
University of Leeds
Leeds Teaching Hospital Trust
Leeds, United Kingdom
Paul Emery, MA, MD, FRCP, is Arthritis Research Campaign Professor of Rheumatology and Head of Academic Unit of Musculoskeletal Medicine at the University of Leeds. He is Clinical Director (Rheumatology) at the Leeds Teaching Hospitals Trust in the United Kingdom.
Professor Emery graduated in medicine from the University of Cambridge and completed specialist accreditation in internal medicine and rheumatology. He completed his thesis on the immunopathology of rheumatoid arthritis at Guy's Hospital, and then served as Head of Rheumatology at the Walter and Eliza Hall Institute in Melbourne. He was senior lecturer in rheumatology at the University of Birmingham, UK from 1987-1995 until his present appointment.
Professor Emery has served as a member of several education committees including the Senior Advisory Committees of the Royal College of Physicians, the MRCP Part 1 Board, and the Special Question Group for Rheumatology/Immunology. He is currently the Treasurer for EULAR, a past member of the Scientific Committee and Chairs the MRI imaging group. He is on the editorial boards of several journals, including Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical and Experimental Rheumatology, Clinical Rheumatology and Modern Rheumatology (Japanese Rheumatology Association Journal).
He is a recipient of the Roche Biennial Award of Clinical Rheumatology, the Rheumatology Hospital Doctor of the Year award 1999 and EULAR prize 2002 for outstanding contribution to Rheumatology research.
Professor Emery's research interests centre around the immunopathogenesis and therapy of rheumatoid arthritis and connective tissue diseases. He has a special interest in the factors leading to persistent inflammation and is a founder member of ERAS, LEAP (Leeds Early Arthritis Project) and YEAR (Yorkshire Early Arthritis Register) and the Leeds Musculoskeletal Imaging Group. He has published over 350 peer reviewed articles in this area.